(Q44425205)

English

Effect of agalsidase alfa replacement therapy on Fabry disease-related hypertrophic cardiomyopathy: a 12- to 36-month, retrospective, blinded echocardiographic pooled analysis

scientific article published in September 2009

Statements

Effect of agalsidase alfa replacement therapy on Fabry disease-related hypertrophic cardiomyopathy: a 12- to 36-month, retrospective, blinded echocardiographic pooled analysis (English)
Christoph Kampmann
Raphael Schiffmann
1 September 2009
1966-1976

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit